Clinical Trial Update: Investigating the Neuroprotective Effect of Cop-1 (Copaxone) in Acute Primary Angle Closure [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating Copaxone (glatiramer acetate) for neuroprotection in acute primary angle-closure glaucoma; current status is not discl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angle-closure Glaucoma

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)

Snippet

Sponsor: Singapore Eye Research Institute | Conditions: Glaucoma, Angle-closure, Primary, Acute | Phase 3 | Status: UNKNOWN